{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:31:01Z","timestamp":1790721061170,"version":"4.1.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00011-018-1129-8","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T03:28:23Z","timestamp":1516850903000},"page":"391-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Vascular endothelium dysfunction: a conservative target in metabolic disorders"],"prefix":"10.1007","volume":"67","author":[{"given":"Shalini","family":"Jamwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"issue":"8","key":"1129_CR1","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","volume":"15","author":"DH Endemann","year":"2004","unstructured":"Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15(8):1983\u201392.","journal-title":"J Am Soc Nephrol"},{"key":"1129_CR2","doi-asserted-by":"crossref","unstructured":"Janus A, et al., Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders. Mediators Inflamm, 2016","DOI":"10.1155\/2016\/3634948"},{"issue":"3","key":"1129_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","volume":"128","author":"D Hilfiker-Kleiner","year":"2007","unstructured":"Hilfiker-Kleiner D, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):p.\u00a0589\u2013600.","journal-title":"Cell"},{"issue":"44","key":"1129_CR4","first-page":"345","volume":"4","author":"S Khan","year":"1997","unstructured":"Khan S, Arakawa O, Onoue Y. Neurotoxin production by a chloromonad Fibrocapsa japonica (Raphidophyceae). Oceanogr Lit Rev. 1997;4(44):345.","journal-title":"Oceanogr Lit Rev"},{"issue":"1","key":"1129_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jcb.240460106","volume":"46","author":"GM Rubanyi","year":"1991","unstructured":"Rubanyi GM. Endothelium-derived relaxing and contracting factors. J Cell Biochem. 1991;46(1):27\u201336.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1129_CR6","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1152\/ajpregu.00323.2002","volume":"284","author":"I Fleming","year":"2003","unstructured":"Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integrative Compar Physiol. 2003;284(1):R1\u2013R12.","journal-title":"Am J Physiol Regul Integrative Compar Physiol"},{"issue":"7","key":"1129_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1172\/JCI7886","volume":"104","author":"Y Tsutsumi","year":"1999","unstructured":"Tsutsumi Y, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Investig. 1999;104(7):925\u201335.","journal-title":"J Clin Investig"},{"key":"1129_CR8","doi-asserted-by":"crossref","unstructured":"Sandoo A, et al., The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J. 2010;4(1).","DOI":"10.2174\/1874192401004010302"},{"issue":"1","key":"1129_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/(SICI)1097-0185(199805)251:1<44::AID-AR8>3.0.CO;2-E","volume":"251","author":"RJ Tomanek","year":"1998","unstructured":"Tomanek RJ, Busch TL. Coordinated capillary and myocardial growth in response to thyroxine treatment. Anatomical Record. 1998;251(1):44\u20139.","journal-title":"Anatomical Record"},{"issue":"11","key":"1129_CR10","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1172\/JCI32024","volume":"117","author":"D Tirziu","year":"2007","unstructured":"Tirziu D, et al. Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Investig. 2007;117(11):3188\u201397.","journal-title":"J Clin Investig"},{"issue":"3","key":"1129_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.bbrc.2003.10.007","volume":"311","author":"SM Dallabrida","year":"2003","unstructured":"Dallabrida SM, et al. Adipose tissue growth and regression are regulated by angiopoietin-1. Biochem Biophys Res Commun. 2003;311(3):563\u201371.","journal-title":"Biochem Biophys Res Commun"},{"key":"1129_CR12","doi-asserted-by":"crossref","unstructured":"Sunshine SB, et al., Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition. Proceedings of the National Academy of Sciences, 2012. 109(28): p.\u00a011306\u201311311.","DOI":"10.1073\/pnas.1203275109"},{"issue":"14","key":"1129_CR13","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1056\/NEJM199804023381403","volume":"338","author":"JN Martin","year":"1998","unstructured":"Martin JN, et al. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998;338(14):948\u201354.","journal-title":"N Engl J Med"},{"issue":"2","key":"1129_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/08941930390194424","volume":"16","author":"AK Greene","year":"2003","unstructured":"Greene AK, Puder M. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg. 2003;16(2):99\u2013102.","journal-title":"J Invest Surg"},{"issue":"6 Suppl","key":"1129_CR15","first-page":"III12","volume":"86","author":"A Lerman","year":"1992","unstructured":"Lerman A, Burnett J Jr. Intact and altered endothelium in regulation of vasomotion. Circulation. 1992;86(6 Suppl):III12\u2013I19.","journal-title":"Circulation"},{"issue":"3","key":"1129_CR16","first-page":"183","volume":"1","author":"HA Hadi","year":"2005","unstructured":"Hadi HA, Carr CS, Suwaidi JA. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vascular Health Risk Manag. 2005;1(3):183.","journal-title":"Vascular Health Risk Manag"},{"issue":"3","key":"1129_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2337\/diacare.27.3.813","volume":"27","author":"JC Pickup","year":"2004","unstructured":"Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813\u201323.","journal-title":"Diabetes Care"},{"issue":"12","key":"1129_CR18","doi-asserted-by":"publisher","first-page":"2751S","DOI":"10.1093\/jn\/128.12.2751S","volume":"128","author":"C Miller","year":"1998","unstructured":"Miller C, et al. Tumor necrosis factor-\u03b1 levels in adipose tissue of lean and obese cats. J Nutr. 1998;128(12):2751S\u20132752S.","journal-title":"J Nutr"},{"issue":"2","key":"1129_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1172\/JCI108933","volume":"61","author":"G Fernandes","year":"1978","unstructured":"Fernandes G, et al. Immune response in the mutant diabetic C57BL\/Ks-dt + mouse. Discrepancies between in vitro and in vivo immunological assays. J Clin Investig. 1978;61(2):243.","journal-title":"J Clin Investig"},{"issue":"1","key":"1129_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/ajcn\/33.1.13","volume":"33","author":"R Chandra","year":"1980","unstructured":"Chandra R. Cell-mediated immunity in genetically obese C57BL\/6J ob\/ob) mice. Am J Clin Nutr. 1980;33(1):13\u20136.","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"1129_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit W, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45(7):1169\u201396.","journal-title":"J Lipid Res"},{"issue":"1","key":"1129_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016;13(1):48\u201360.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"1129_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/hep.28283","volume":"63","author":"M Goffredo","year":"2016","unstructured":"Goffredo M, et al. Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: a multiethnic study. Hepatology. 2016;63(1):117\u201325.","journal-title":"Hepatology"},{"issue":"23","key":"1129_CR24","doi-asserted-by":"publisher","first-page":"17399","DOI":"10.1074\/jbc.M002248200","volume":"275","author":"A Huang","year":"2000","unstructured":"Huang A, et al. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem. 2000;275(23):17399\u2013406.","journal-title":"J Biol Chem"},{"issue":"6","key":"1129_CR25","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1210\/en.2003-0285","volume":"144","author":"CJ Lyon","year":"2003","unstructured":"Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology. 2003;144(6):2195\u2013200.","journal-title":"Endocrinology"},{"key":"1129_CR26","doi-asserted-by":"crossref","unstructured":"Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction a marker of atherosclerotic risk. Arteriosclerosis, thrombosis, and vascular biology. 2003. 23(2):168\u201375.","DOI":"10.1161\/01.ATV.0000051384.43104.FC"},{"key":"1129_CR27","unstructured":"Chatrchyan S, et al., The CMS experiment at the CERN LHC. 2008."},{"key":"1129_CR28","doi-asserted-by":"crossref","unstructured":"Ventura A, et al., Cre-lox-regulated conditional RNA interference from transgenes. Proceedings of the National Academy of Sciences of the United States of America, 2004. 101(28): p.\u00a010380\u201310385.","DOI":"10.1073\/pnas.0403954101"},{"issue":"6","key":"1129_CR29","first-page":"589","volume":"74","author":"A Boldyrev","year":"2009","unstructured":"Boldyrev A. Molecular mechanisms of homocysteine toxicity. Biochemistry. 2009;74(6):589\u201398.","journal-title":"Biochemistry"},{"key":"1129_CR30","doi-asserted-by":"crossref","unstructured":"Muravyov A, Tikhomirova I. Role Ca2+ in mechanisms of the red blood cells microrheological changes, in Calcium Signaling. 2012, Springer. 1017\u201338.","DOI":"10.1007\/978-94-007-2888-2_47"},{"key":"1129_CR31","doi-asserted-by":"crossref","unstructured":"PINO P, et al., Redox-dependent apoptosis in human endothelial cells after adhesion of plasmodium falciparum-infected erythrocytes. Annals of the New York Academy of Sciences, 2003. 1010(1):582\u20136.","DOI":"10.1196\/annals.1299.109"},{"key":"1129_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0065-2776(08)60379-X","volume":"34","author":"MB Pepys","year":"1983","unstructured":"Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141\u2013212.","journal-title":"Adv Immunol"},{"issue":"47","key":"1129_CR33","doi-asserted-by":"publisher","first-page":"48487","DOI":"10.1074\/jbc.R400025200","volume":"279","author":"S Black","year":"2004","unstructured":"Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279(47):48487\u201390.","journal-title":"J Biol Chem"},{"issue":"12","key":"1129_CR34","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Investig. 2003;111(12):1805\u201312.","journal-title":"J Clin Investig"},{"issue":"20","key":"1129_CR35","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557\u201365.","journal-title":"N Engl J Med"},{"issue":"3","key":"1129_CR36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","volume":"100","author":"PM Ridker","year":"1999","unstructured":"Ridker PM, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 1999;100(3):p.\u00a0230\u20135.","journal-title":"Circulation"},{"issue":"6","key":"1129_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.amjmed.2004.02.006","volume":"116","author":"P Libby","year":"2004","unstructured":"Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004;116(6):9\u201316.","journal-title":"Am J Med"},{"issue":"1","key":"1129_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJMoa042000","volume":"352","author":"SE Nissen","year":"2005","unstructured":"Nissen SE, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005;352(1):29\u201338.","journal-title":"N Engl J Med"},{"issue":"1","key":"1129_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa042378","volume":"352","author":"PM Ridker","year":"2005","unstructured":"Ridker PM, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352(1):20\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"1129_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11892-005-0062-8","volume":"5","author":"LJ Ignarro","year":"2005","unstructured":"Ignarro LJ, Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Diabetes Rep. 2005;5(1):17\u201323.","journal-title":"Curr Diabetes Rep"},{"issue":"3","key":"1129_CR41","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cardiores.2005.01.026","volume":"66","author":"I Valle","year":"2005","unstructured":"Valle I, et al. PGC-1\u03b1 regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res. 2005;66(3):562\u201373.","journal-title":"Cardiovasc Res"},{"issue":"6865","key":"1129_CR42","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/414782a","volume":"414","author":"P Zimmet","year":"2001","unstructured":"Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782\u20137.","journal-title":"Nature"},{"issue":"2","key":"1129_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1503\/cmaj.1031414","volume":"172","author":"AY Cheng","year":"2005","unstructured":"Cheng AY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. Can Med Assoc J. 2005;172(2):213\u201326.","journal-title":"Can Med Assoc J"},{"key":"1129_CR44","doi-asserted-by":"publisher","first-page":"S43-S48","DOI":"10.1016\/S1262-3636(08)73394-9","volume":"34","author":"P-J Guillausseau","year":"2008","unstructured":"Guillausseau P-J, et al. Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab. 2008;34:p.\u00a0S43-S48.","journal-title":"Diabetes Metab"},{"issue":"6706","key":"1129_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"Y Min-Jean","year":"1998","unstructured":"Min-Jean Y, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IkappaB kinase-beta. Nature. 1998;396(6706):77.","journal-title":"Nature"},{"issue":"12","key":"1129_CR46","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1074\/jbc.275.12.9047","volume":"275","author":"V Aguirre","year":"2000","unstructured":"Aguirre V, et al. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J Biol Chem. 2000;275(12):9047\u201354.","journal-title":"J Biol Chem"},{"issue":"5249","key":"1129_CR47","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.271.5249.665","volume":"271","author":"GS Hotamisligil","year":"1996","unstructured":"Hotamisligil GS, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science. 1996;271(5249):665.","journal-title":"Science"},{"issue":"2","key":"1129_CR48","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1074\/jbc.M101521200","volume":"277","author":"V Aguirre","year":"2002","unstructured":"Aguirre V, et al. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem. 2002;277(2):1531\u20137.","journal-title":"J Biol Chem"},{"issue":"47","key":"1129_CR49","doi-asserted-by":"publisher","first-page":"29911","DOI":"10.1074\/jbc.272.47.29911","volume":"272","author":"K Paz","year":"1997","unstructured":"Paz K, et al. A Molecular Basis for Insulin Resistance elevated serine\/threonine phosphorylation of irs-1 and irs-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem. 1997;272(47):29911\u20138.","journal-title":"J Biol Chem"},{"issue":"6","key":"1129_CR50","first-page":"853","volume":"3","author":"HA Hadi","year":"2007","unstructured":"Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vascular health risk management. 2007;3(6):p.\u00a0853.","journal-title":"Vascular health risk management"},{"issue":"4","key":"1129_CR51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2478\/rjdnmd-2013-0042","volume":"20","author":"C Muntean","year":"2013","unstructured":"Muntean C, et al. Biochemistry of hyperglycemia induced vascular dysfunction. Roman J Diabet Nutr Metab Dis. 2013;20(4):419\u201325.","journal-title":"Roman J Diabet Nutr Metab Dis"},{"issue":"5262","key":"1129_CR52","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.272.5262.728","volume":"272","author":"H Ishii","year":"1996","unstructured":"Ishii H, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science. 1996;272(5262):728.","journal-title":"Science"},{"issue":"9","key":"1129_CR53","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058\u201370.","journal-title":"Circ Res"},{"issue":"1","key":"1129_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncpendmet0366","volume":"3","author":"C Rask-Madsen","year":"2007","unstructured":"Rask-Madsen C, King GL. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab. 2007;3(1):46\u201356.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1129_CR55","doi-asserted-by":"crossref","unstructured":"Schoch CL, et al., Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proceedings of the National Academy of Sciences, 2012. 109(16): p.\u00a06241\u20136246.","DOI":"10.1073\/pnas.1117018109"},{"key":"1129_CR56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bcp.2016.01.005","volume":"104","author":"CA Headley","year":"2016","unstructured":"Headley CA, et al. Nitrones reverse hyperglycemia-induced endothelial dysfunction in bovine aortic endothelial cells. Biochem Pharmacol. 2016;104:108\u201317.","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"1129_CR57","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/j.1464-5491.2009.02847.x","volume":"26","author":"S Prato Del","year":"2009","unstructured":"Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies. Diabetic Med. 2009;26(12):1185\u201392.","journal-title":"Diabetic Med"},{"key":"1129_CR58","doi-asserted-by":"crossref","unstructured":"Musicki B, et al., Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proceedings of the National Academy of Sciences of the United States of America, 2005. 102(33): p.\u00a011870\u201311875.","DOI":"10.1073\/pnas.0502488102"},{"issue":"2","key":"1129_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2215\/CJN.00990905","volume":"1","author":"TA McGowan","year":"2006","unstructured":"McGowan TA, et al. Stimulation of urinary TGF-\u03b2 and isoprostanes in response to hyperglycemia in humans. Clin J Am Soc Nephrol. 2006;1(2):263\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1129_CR60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0021-9150(01)00574-3","volume":"160","author":"I Gabriely","year":"2002","unstructured":"Gabriely I, et al. Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway. Atherosclerosis. 2002;160(1):115\u201322.","journal-title":"Atherosclerosis"},{"issue":"1","key":"1129_CR61","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2013.06.017","volume":"230","author":"MC Gage","year":"2013","unstructured":"Gage MC, et al. Endothelium-specific insulin resistance leads to accelerated atherosclerosis in areas with disturbed flow patterns: a role for reactive oxygen species. Atherosclerosis. 2013;230(1):131\u20139.","journal-title":"Atherosclerosis"},{"issue":"18","key":"1129_CR62","doi-asserted-by":"publisher","first-page":"12467","DOI":"10.1074\/jbc.M114.554162","volume":"289","author":"NJ Han\u00e7er","year":"2014","unstructured":"Han\u00e7er NJ, et al. Insulin and metabolic stress stimulate multisite serine\/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation. J Biol Chem. 2014;289(18):12467\u201384.","journal-title":"J Biol Chem"},{"issue":"2","key":"1129_CR63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pharmthera.2012.08.002","volume":"136","author":"M Kaplan","year":"2012","unstructured":"Kaplan M, Aviram M, Hayek T. Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: Role of insulin therapy. Pharmacology therapeutics. 2012;136(2):p.\u00a0175\u201385.","journal-title":"Pharmacology therapeutics"},{"issue":"6","key":"1129_CR64","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11906-012-0307-2","volume":"14","author":"AR Wende","year":"2012","unstructured":"Wende AR, Symons JD, Abel ED. Mechanisms of lipotoxicity in the cardiovascular system. Curr Hypertension Rep. 2012;14(6):517\u201331.","journal-title":"Curr Hypertension Rep"},{"issue":"2","key":"1129_CR65","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijcard.2010.07.019","volume":"152","author":"H Li","year":"2011","unstructured":"Li H, et al. Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-\u03baB pathway in rat aorta. Int J Cardiol. 2011;152(2):218\u201324.","journal-title":"Int J Cardiol"},{"issue":"11","key":"1129_CR66","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2337\/diabetes.49.11.1939","volume":"49","author":"T Inoguchi","year":"2000","unstructured":"Inoguchi T, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD (P) H oxidase in cultured vascular cells. Diabetes. 2000;49(11):1939\u201345.","journal-title":"Diabetes"},{"issue":"1","key":"1129_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-9-9","volume":"9","author":"M Mathew","year":"2010","unstructured":"Mathew M, Tay E, Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol. 2010;9(1):1.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1129_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1476-5381.2010.01196.x","volume":"164","author":"U F\u00f6rstermann","year":"2011","unstructured":"F\u00f6rstermann U, Li H. Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol. 2011;164(2):213\u201323.","journal-title":"Br J Pharmacol"},{"issue":"9591","key":"1129_CR69","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0140-6736(07)61437-8","volume":"370","author":"V Beral","year":"2007","unstructured":"Beral V, et al. Ovarian cancer and hormone replacement therapy\u2013Authors\u2019 reply. The Lancet. 2007;370(9591):932\u20133.","journal-title":"The Lancet"},{"issue":"6","key":"1129_CR70","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1113\/expphysiol.2006.035493","volume":"91","author":"B Casadei","year":"2006","unstructured":"Casadei B. The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function. Exp Physiol. 2006;91(6):943\u201355.","journal-title":"Exp Physiol"},{"issue":"1","key":"1129_CR71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/dmrr.255","volume":"18","author":"KC Tan","year":"2002","unstructured":"Tan KC, et al. Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria. Diabetes\/Metab Res Rev. 2002;18(1):71\u20136.","journal-title":"Diabetes\/Metab Res Rev"},{"issue":"15","key":"1129_CR72","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","volume":"113","author":"J-a Kim","year":"2006","unstructured":"Kim J-a, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction. Circulation. 2006;113(15):1888\u2013904.","journal-title":"Circulation"},{"issue":"3","key":"1129_CR73","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0735-1097(95)00522-6","volume":"27","author":"SB Williams","year":"1996","unstructured":"Williams SB, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27(3):567\u201374.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1129_CR74","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1172\/JCI115179","volume":"87","author":"B Tesfamariam","year":"1991","unstructured":"Tesfamariam B, Brown ML, Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Investig. 1991;87(5):1643.","journal-title":"J Clin Investig"},{"issue":"7","key":"1129_CR75","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/S0735-1097(00)00980-3","volume":"36","author":"LM Title","year":"2000","unstructured":"Title LM, et al. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol. 2000;36(7):2185\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1129_CR76","doi-asserted-by":"publisher","first-page":"PL147","DOI":"10.1016\/0024-3205(95)02360-7","volume":"58","author":"GM Pieper","year":"1996","unstructured":"Pieper GM, Moore-Hilton G, Roza AM. Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci. 1996;58(9):PL147\u2013PL152.","journal-title":"Life Sci"},{"issue":"9","key":"1129_CR77","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1172\/JCI11235","volume":"108","author":"XL Du","year":"2001","unstructured":"Du XL, et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Investig. 2001;108(9):1341\u20138.","journal-title":"J Clin Investig"},{"issue":"3","key":"1129_CR78","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2337\/diabetes.47.3.457","volume":"47","author":"A Veves","year":"1998","unstructured":"Veves A, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998;47(3):457\u201363.","journal-title":"Diabetes"},{"key":"1129_CR79","unstructured":"Boudi BF. Noncoronary Atherosclerosis. Medscape."},{"issue":"1","key":"1129_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0100-879X2009007500021","volume":"43","author":"S Brustolin","year":"2010","unstructured":"Brustolin S, Giugliani R, F\u00e9lix T. Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res. 2010;43(1):1\u20137.","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"1129_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-014-0476-2","volume":"14","author":"A Jayaraman","year":"2014","unstructured":"Jayaraman A, Pike CJ. Alzheimer\u2019s disease and type 2 diabetes: multiple mechanisms contribute to interactions. Current diabetes reports. 2014;14(4):1\u20139.","journal-title":"Current diabetes reports"},{"issue":"1","key":"1129_CR82","first-page":"8","volume":"17","author":"T Huang","year":"2008","unstructured":"Huang T, et al. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pacific J Clin Nutr. 2008;17(1):8\u201316.","journal-title":"Asia Pacific J Clin Nutr"},{"issue":"2","key":"1129_CR83","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257\u201365.","journal-title":"J Am Coll Cardiol"},{"key":"1129_CR84","doi-asserted-by":"crossref","unstructured":"Tasatargil A, Sadan G, Karasu E. Homocysteine-induced changes in vascular reactivity of guinea-pig pulmonary arteries: role of the oxidative stress and poly (ADP-ribose) polymerase activation. Pulmonary pharmacology & therapeutics, 2007. 20(3):265\u201372.","DOI":"10.1016\/j.pupt.2006.02.004"},{"issue":"11","key":"1129_CR85","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1440-1681.2010.05438.x","volume":"37","author":"TT Yan","year":"2010","unstructured":"Yan TT, et al. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor\/Akt\/endothelial nitric oxide synthase signalling. Clin Exp Pharmacol Physiol. 2010;37(11):1071\u20137.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"1129_CR86","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/jn\/136.8.2141","volume":"136","author":"CP Lima","year":"2006","unstructured":"Lima CP, et al. Vitamin B-6 deficiency suppresses the hepatic transsulfuration pathway but increases glutathione concentration in rats fed AIN-76A or AIN-93G diets. J Nutr. 2006;136(8):2141\u20137.","journal-title":"J Nutr"},{"issue":"3","key":"1129_CR87","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/1358863X08100834","volume":"14","author":"E Jahangir","year":"2009","unstructured":"Jahangir E, et al. The effect of L-arginine and creatine on vascular function and homocysteine metabolism. Vascular Med. 2009;14(3):239\u201348.","journal-title":"Vascular Med"},{"issue":"4","key":"1129_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1567-5688(03)00035-7","volume":"4","author":"SR Lentz","year":"2003","unstructured":"Lentz SR, Rodionov RN, Dayal S. Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA. Atherosclerosis Supplements. 2003;4(4):61\u20135.","journal-title":"Atherosclerosis Supplements"},{"issue":"1","key":"1129_CR89","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0008-6363(02)00617-X","volume":"57","author":"K Sydow","year":"2003","unstructured":"Sydow K, et al. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. Cardiovascular Res. 2003;57(1):244\u201352.","journal-title":"Cardiovascular Res"},{"issue":"5","key":"1129_CR90","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1161\/01.CIR.95.5.1119","volume":"95","author":"A Tawakol","year":"1997","unstructured":"Tawakol A, et al. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997;95(5):1119\u201321.","journal-title":"Circulation"},{"issue":"6","key":"1129_CR91","doi-asserted-by":"publisher","first-page":"H2649-H2656","DOI":"10.1152\/ajpheart.00548.2005","volume":"289","author":"N Tyagi","year":"2005","unstructured":"Tyagi N, et al. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol. 2005;289(6):H2649-H2656.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1129_CR92","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1067\/mai.2001.112129","volume":"107","author":"HS Skolnick","year":"2001","unstructured":"Skolnick HS, et al. The natural history of peanut allergy. J Allergy Clin Immunol. 2001;107(2):367\u201374.","journal-title":"J Allergy Clin Immunol"},{"key":"1129_CR93","doi-asserted-by":"crossref","unstructured":"Lacy P. Secretion of cytokines and chemokines by innate immune cells. 2015: Frontiers Media SA.","DOI":"10.3389\/978-2-88919-550-3"},{"issue":"7","key":"1129_CR94","doi-asserted-by":"publisher","first-page":"e0158672","DOI":"10.1371\/journal.pone.0158672","volume":"11","author":"Y Dong","year":"2016","unstructured":"Dong Y, et al. Nitrative stress participates in endothelial progenitor cell injury in hyperhomocysteinemia. PloS One. 2016;11(7):e0158672.","journal-title":"PloS One"},{"issue":"1","key":"1129_CR95","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S1051-2276(98)90035-8","volume":"8","author":"S-Y Hong","year":"1998","unstructured":"Hong S-Y, Yang D-H, Chang S-K. The relationship between plasma homocysteine and amino acid concentrations in patients with end-stage renal disease. J Renal Nutr. 1998;8(1):34\u20139.","journal-title":"J Renal Nutr"},{"key":"1129_CR96","doi-asserted-by":"crossref","unstructured":"van Dijk SC, et al., Effect of vitamin B12 and folic acid supplementation on biomarkers of endothelial function and inflammation among elderly individuals with hyperhomocysteinemia. Vascular Medicine, 2016;1358863 \u00d7 15622281.","DOI":"10.1177\/1358863X15622281"},{"issue":"1","key":"1129_CR97","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2015.07.021","volume":"242","author":"X-C Wang","year":"2015","unstructured":"Wang X-C, et al. ER stress mediates homocysteine-induced endothelial dysfunction: Modulation of IK Ca and SK Ca channels. Atherosclerosis. 2015;242(1):191\u20138.","journal-title":"Atherosclerosis"},{"issue":"5","key":"1129_CR98","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ajh.2008.16","volume":"21","author":"LM Ruilope","year":"2008","unstructured":"Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertension. 2008;21(5):500\u20138.","journal-title":"Am J Hypertension"},{"issue":"17","key":"1129_CR99","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, et al. Kidney disease as a risk factor for development of cardiovascular disease a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108(17):2154\u201369.","journal-title":"Circulation"},{"key":"1129_CR100","unstructured":"Arora P, Arora A, Sharma S. Vascular endothelium dysfunction and hypertension: insight on molecular basics."},{"issue":"5","key":"1129_CR101","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1172\/JCI88532","volume":"127","author":"K Kitada","year":"2017","unstructured":"Kitada K, et al. High salt intake reprioritizes osmolyte and energy metabolism for body fluid conservation. J Clin Investig. 2017;127(5):1944\u201359.","journal-title":"J Clin Investig"},{"issue":"6654","key":"1129_CR102","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/40187","volume":"389","author":"M Uehata","year":"1997","unstructured":"Uehata M, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389(6654):990\u20134.","journal-title":"Nature"},{"issue":"2","key":"1129_CR103","doi-asserted-by":"publisher","first-page":"A59","DOI":"10.1016\/0002-9149(87)90178-0","volume":"59","author":"VJ Dzau","year":"1987","unstructured":"Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol. 1987;59(2):A59\u2013A65.","journal-title":"Am J Cardiol"},{"issue":"4","key":"1129_CR104","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1254\/jphs.10R06FM","volume":"113","author":"A Nishiyama","year":"2010","unstructured":"Nishiyama A, et al. New approaches to blockade of the renin-angiotensin-aldosterone system: mineralocorticoid-receptor blockers exert antihypertensive and renoprotective effects independently of the renin-angiotensin system. J Pharmacol Sci. 2010;113(4):310\u20134.","journal-title":"J Pharmacol Sci"},{"issue":"10","key":"1129_CR105","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","volume":"87","author":"H Cai","year":"2000","unstructured":"Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87(10):840\u20134.","journal-title":"Circ Res"},{"issue":"5","key":"1129_CR106","first-page":"1516","volume":"82","author":"H Nishimura","year":"1999","unstructured":"Nishimura H, et al. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thrombosis Haemostasis. 1999;82(5):1516\u201321.","journal-title":"Thrombosis Haemostasis"},{"issue":"6","key":"1129_CR107","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1055\/s-0038-1656136","volume":"77","author":"H Nishimura","year":"1997","unstructured":"Nishimura H, et al. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thrombosis Haemostasis. 1997;77(6):1189\u201395.","journal-title":"Thrombosis Haemostasis"},{"issue":"6","key":"1129_CR108","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.RES.77.6.1053","volume":"77","author":"M Ishida","year":"1995","unstructured":"Ishida M, et al. Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res. 1995;77(6):1053\u20139.","journal-title":"Circ Res"},{"issue":"6","key":"1129_CR109","first-page":"349","volume":"35","author":"D Badyal","year":"2003","unstructured":"Badyal D, Lata H, Dadhich A. Animal models of hypertension and effect of drugs. Indian J Pharmacol. 2003;35(6):349\u201362.","journal-title":"Indian J Pharmacol"},{"issue":"6","key":"1129_CR110","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","volume":"74","author":"KK Griendling","year":"1994","unstructured":"Griendling KK, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74(6):1141\u20138.","journal-title":"Circ Res"},{"issue":"6","key":"1129_CR111","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/01.RES.0000216039.75913.9e","volume":"98","author":"JH Brown","year":"2006","unstructured":"Brown JH, Del Re DP, Sussman MA. The Rac and Rho hall of fame a decade of hypertrophic signaling hits. Circ Res. 2006;98(6):730\u201342.","journal-title":"Circ Res"},{"issue":"3","key":"1129_CR112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","volume":"24","author":"G Burnstock","year":"1972","unstructured":"Burnstock G. Purinergic nerves. Pharmacol Rev. 1972;24(3):509\u201381.","journal-title":"Pharmacol Rev"},{"issue":"8","key":"1129_CR113","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1084\/jem.20040995","volume":"201","author":"C Vecchione","year":"2005","unstructured":"Vecchione C, et al. Protection from angiotensin II\u2013mediated vasculotoxic and hypertensive response in mice lacking PI3K\u03b3. J Exp Med. 2005;201(8):1217\u201328.","journal-title":"J Exp Med"},{"key":"1129_CR114","doi-asserted-by":"crossref","unstructured":"Rubattu S, Stanzione R, Volpe M. Mitochondrial dysfunction contributes to hypertensive target organ damage: lessons from an animal model of human disease. Oxidative Medicine and Cellular Longevity, 2016.","DOI":"10.1155\/2016\/1067801"},{"issue":"1","key":"1129_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2009.07.031","volume":"314","author":"E Maury","year":"2010","unstructured":"Maury E, Brichard S. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314(1):1\u201316.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"1129_CR116","doi-asserted-by":"publisher","first-page":"L733","DOI":"10.1152\/ajplung.2000.279.4.L733","volume":"279","author":"EO Harrington","year":"2000","unstructured":"Harrington EO, et al. Adenosine induces endothelial apoptosis by activating protein tyrosine phosphatase: a possible role of p38\u03b1. Am J Physiol Lung Cell Mol Physiol. 2000;279(4):L733\u2013L742.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9\u201310","key":"1129_CR117","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1089\/ars.2005.7.1302","volume":"7","author":"RM Touyz","year":"2005","unstructured":"Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxidants Redox Signal. 2005;7(9\u201310):1302\u201314.","journal-title":"Antioxidants Redox Signal"},{"issue":"18","key":"1129_CR118","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1089\/ars.2013.5566","volume":"20","author":"JK Bendall","year":"2014","unstructured":"Bendall JK, et al. Tetrahydrobiopterin in cardiovascular health and disease. Antioxidants redox signaling. 2014;20(18):p.\u00a03040\u201377.","journal-title":"Antioxidants redox signaling"},{"key":"1129_CR119","unstructured":"Hausding M, et al., Molecular Mechanisms of the Crosstalk Between Mitochondria and NADPH Oxidase Through Reactive Oxygen Species\u2014Studies in White Blood Cells and in Animal Models."},{"key":"1129_CR120","doi-asserted-by":"crossref","unstructured":"Jin M, et al., Uric acid, hyperuricemia and vascular diseases. Frontiers in bioscience: a journal and virtual library. 2012. 17:656.","DOI":"10.2741\/3950"},{"issue":"3","key":"1129_CR121","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000355405","volume":"3","author":"K Chaudhary","year":"2013","unstructured":"Chaudhary K, et al. Uric Acid-key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 2013;3(3):208\u201320.","journal-title":"Cardiorenal Med"},{"issue":"10","key":"1129_CR122","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s12272-014-0413-6","volume":"37","author":"J Su","year":"2014","unstructured":"Su J, et al. Anti-hyperuricemic and nephroprotective effects of Rhizoma Dioscoreae septemlobae extracts and its main component dioscin via regulation of mOAT1, mURAT1 and mOCT2 in hypertensive mice. Arch Pharmacal Res. 2014;37(10):1336\u201344.","journal-title":"Arch Pharmacal Res"},{"issue":"10","key":"1129_CR123","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.phymed.2014.03.009","volume":"21","author":"X-H Wu","year":"2014","unstructured":"Wu X-H, et al. Riparoside B and timosaponin J, two steroidal glycosides from Smilax riparia, resist to hyperuricemia based on URAT1 in hyperuricemic mice. Phytomedicine. 2014;21(10):1196\u2013201.","journal-title":"Phytomedicine"},{"key":"1129_CR124","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1038\/srep03755","volume":"4","author":"H Matsuo","year":"2014","unstructured":"Matsuo H, et al. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. Sci Rep. 2014;4:3755.","journal-title":"Sci Rep"},{"issue":"3","key":"1129_CR125","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","volume":"59","author":"P Puddu","year":"2012","unstructured":"Puddu P, et al. The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: molecular mechanisms and clinical implications. J Cardiol. 2012;59(3):235\u201342.","journal-title":"J Cardiol"},{"issue":"2","key":"1129_CR126","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/08037050802029954","volume":"17","author":"P Puddu","year":"2008","unstructured":"Puddu P, et al. The molecular sources of reactive oxygen species in hypertension. Blood Pressure. 2008;17(2):70\u20137.","journal-title":"Blood Pressure"},{"issue":"8","key":"1129_CR127","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/j.1538-7836.2005.01370.x","volume":"3","author":"R Stocker","year":"2005","unstructured":"Stocker R, Keaney J. New insights on oxidative stress in the artery wall. J Thromb Haemost. 2005;3(8):1825\u201334.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"1129_CR128","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1172\/JCI116491","volume":"91","author":"Y Ohara","year":"1993","unstructured":"Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Investig. 1993;91(6):2546.","journal-title":"J Clin Investig"},{"issue":"3","key":"1129_CR129","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.mn.7800136","volume":"9","author":"A Meneshian","year":"2002","unstructured":"Meneshian A, Bulkley GB. The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation. 2002;9(3):161\u201375.","journal-title":"Microcirculation"},{"issue":"3","key":"1129_CR130","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","volume":"555","author":"CE Berry","year":"2004","unstructured":"Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol. 2004;555(3):589\u2013606.","journal-title":"J Physiol"},{"issue":"1","key":"1129_CR131","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2147\/VHRM.S4265","volume":"5","author":"J George","year":"2009","unstructured":"George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag. 2009;5(1):265\u201372.","journal-title":"Vasc Health Risk Manag"},{"issue":"17","key":"1129_CR132","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"1129_CR133","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10549-011-1693-x","volume":"133","author":"C Panis","year":"2012","unstructured":"Panis C, et al. Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treatment. 2012;133(1):89\u201397.","journal-title":"Breast Cancer Res Treatment"},{"issue":"2","key":"1129_CR134","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/BOR.0b013e3283257b96","volume":"21","author":"NL Edwards","year":"2009","unstructured":"Edwards NL. The role of hyperuricemia in vascular disorders. Curr Opin Rheumatol. 2009;21(2):132\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"1129_CR135","doi-asserted-by":"crossref","unstructured":"Kanellis J, Kang D-H. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. In: Seminars in nephrology. 2005. Elsevier.","DOI":"10.1016\/j.semnephrol.2004.09.007"},{"issue":"6","key":"1129_CR136","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287\u201393.","journal-title":"Hypertension"},{"issue":"1","key":"1129_CR137","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/0961203315600539","volume":"25","author":"D Castillo-Mart\u00ednez","year":"2016","unstructured":"Castillo-Mart\u00ednez D, et al. Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study. Lupus. 2016;25(1):61\u20136.","journal-title":"Lupus"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-018-1129-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-018-1129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-018-1129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T20:34:48Z","timestamp":1751229288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-018-1129-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":137,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1007\/s00011-018-1129-8","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"13 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}